SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after reporting its first-ever quarterly adjusted operating profit and robust Q1 delivery guidance, prompting excitement among bulls who view strong margins and record deliveries as a significant turning point. The community is actively engaged in a debate over sustained profitability and a potential short squeeze, as the stock encounters a critical resistance level amid high trading volume.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is surging as the community celebrates a key FDA official's departure, viewed as clearing a major hurdle for Deramiocel's approval for Duchenne Muscular Dystrophy, with strong Phase 3 data to be highlighted at an upcoming conference fueling expectations for a swift regulatory decision.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as the community eagerly anticipates its upcoming Bankable Feasibility Study, which many expect to reveal a significantly higher valuation for the Tanbreez heavy rare earth project; this comes amid active discussion on the stock's strategic importance in the global 'minerals arms race' driven by escalating geopolitical tensions.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is seeing significant investor attention following a substantial Q4 EPS beat and accelerating revenue from its rare disease drug, MIPLYFFA, sparking community discussions about its unexpected profitability and potential for a valuation re-rating or acquisition.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is gaining traction ahead of upcoming earnings and M&A speculation, with investors keenly focused on a vote regarding Ryan Cohen's compensation package while simultaneously anticipating a significant short squeeze against perceived institutional price suppression around key levels.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the community eagerly awaits Phase 3 REGAL trial results, with many interpreting the trial's extended timeline and positive Independent Data Monitoring Committee recommendations as strong indicators of potential curative outcomes. This anticipation is fueling significant bullish sentiment, widespread discussions of a short squeeze, and buyout speculation, despite ongoing short-seller activity and bearish commentary.

CitroTech, Inc. is an integrated environmental service company, which engages in the provision of field services, remediation transportation, and EHS compliance services. It also offers on-site technical services, on-site and off-site treatment for hazardous and non-hazardous waste. The company was founded on March 14, 1990 and is headquartered in Cheyenne, WY.

CitroTech Inc.

CitroTech Inc. is trending as it presents its differentiated, non-toxic fire-retardant wood technology at an investment conference, aligning with increasing demand driven by escalating wildfires. The community is actively discussing its low float and commercial traction as key factors for potential significant re-pricing and increased investor attention.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is the subject of intense debate ahead of its earnings report, driven by investor concerns over massive capital expenditures and rising debt for AI cloud infrastructure. While community sentiment is bearish on spending and "AI scam" narratives, many bulls see an undervalued opportunity with exploding cloud demand and a substantial contracted revenue backlog.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending due to intense market debate surrounding the ongoing US-Iran conflict, with community discussions polarized between those anticipating further rallies despite geopolitical tensions and others decrying perceived market manipulation and volatility, exacerbated by conflicting reports and unpredictable option premium movements.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing a massive surge driven by its strategic partnership with Novo Nordisk to distribute branded GLP-1s and the resolution of their patent lawsuit, alleviating a significant commercial overhang. The community is buzzing with bullish sentiment, anticipating a powerful short squeeze fueled by high short interest and recent analyst upgrades, projecting substantial upward price movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

First Trust Advisors LP Decreases Stock Position in Docusign Inc. $DOCU

First Trust Advisors LP trimmed its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 12.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange...

Docusign (DOCU) to Release Earnings on Tuesday

Docusign (NASDAQ:DOCU) will be releasing its Q4 2026 earnings after the market closes on Tuesday, March 17. (View Earnings Report at...

Vinva Investment Management Ltd Buys 133,630 Shares of Docusign Inc. $DOCU

Vinva Investment Management Ltd lifted its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 1,017.0% during the 3rd quarter, according to the company in its most recent disclosure with...

Docusign Inc. $DOCU Shares Sold by Blair William & Co. IL

Blair William & Co. IL trimmed its holdings in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 30.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The...

Docusign Inc. $DOCU Shares Purchased by Neuberger Berman Group LLC

Neuberger Berman Group LLC grew its position in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 145.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the...

Munich Reinsurance Co Stock Corp in Munich Acquires New Position in Docusign Inc. $DOCU

Munich Reinsurance Co Stock Corp in Munich acquired a new stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities...

Crossmark Global Holdings Inc. Acquires 45,235 Shares of Docusign Inc. $DOCU

Crossmark Global Holdings Inc. grew its holdings in Docusign Inc. (NASDAQ:DOCU - Free Report) by 364.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The...

Docusign (NASDAQ:DOCU) Director Sells $16,817.79 in Stock

Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Anna Marrs sold 363 shares of the company's stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of...

Docusign (NASDAQ:DOCU) Director Anna Marrs Sells 363 Shares

Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Anna Marrs sold 363 shares of the stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $46.33, for a...

What's Going On With DocuSign Stock Thursday?

DocuSign (DOCU) joins Anthropic's Cowork platform! Shares surge here's what to expect from the March 17 earnings report.read more...

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.95	--	--	N/A
Q3 '25	$0.92	$1.01	10.31%	BEAT
Q2 '25	$0.85	$0.92	8.66%	BEAT
Q1 '25	$0.81	$0.90	10.90%	BEAT
Q4 '24	$0.85	$0.86	1.01%	BEAT

DOCU
DocuSign Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest DOCU News

DOCUDocuSign Inc